Dowling & Yahnke’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$68K Sell
2,113
-1,000
-32% -$37.1K ﹤0.01% 366
2022
Q2
$125K Buy
+3,113
New +$227K 0.01% 366

Other funds holding SNCE

Dowling & Yahnke's SNCE Position: Q3 2022 in Review

Dowling & Yahnke reduced its Science 37 Holdings, Inc. Common Stock (SNCE) stake by 32% in Q3 2022, selling an estimated $37.1K and leaving 2,113 shares worth $68K. The position accounts for ﹤0.01% of the portfolio, ranked #366.

Dowling & Yahnke first reported a position in SNCE in Q2 2022 and has held it in 2 quarters since. The position peaked at $125K in Q2 2022. 68 funds tracked by Wall St. Rank hold SNCE as of Q3 2022.

  • Dowling & Yahnke held 2,113 shares of Science 37 Holdings, Inc. Common Stock worth $68K as of Q3 2022.
  • Dowling & Yahnke sold 1,000 Science 37 Holdings, Inc. Common Stock shares in Q3 2022, an estimated $37.1K.
  • Science 37 Holdings, Inc. Common Stock made up ﹤0.01% of Dowling & Yahnke's portfolio in Q3 2022, its #366 holding.
  • Dowling & Yahnke first reported a position in Science 37 Holdings, Inc. Common Stock in Q2 2022 and has held it in 2 quarters since.
  • Dowling & Yahnke's Science 37 Holdings, Inc. Common Stock position peaked at $125K in Q2 2022.
  • 68 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q3 2022.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.